Preventive Cardiology provides practical advice on how to structure and run a preventive cardiology programme for existing patients, those at risk of developing cardiovascular disease, and their families, including patient identification and recruitment, assessment of lifestyle and risk factors, and implementing lifestyle change
This is a highly practical resource focusing on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors.
This second edition provides an updated review on the current guidelines and practice standards for the clinical management of cardiovascular risk factors and prevention of cardiovascular diseases.
This valuable new edition provides clinical cardiologists, internists, primary care providers, and allied health care professionals with the tools and understanding necessary for their practice in preventive cardiology.
"EACPR, European Association for Cardiovascular Prevention and Rehabilitation -- European Society of Cardiology."
The ESC Handbook of Preventive Cardiology is a 'how-to' manual for busy healthcare professionals.
With access to the fully searchable text online at www.expertconsult.com, this authoritative reference gives you the clinically relevant information you need for the effective prevention of cardiovascular disease.
In fact, the role of LDL-C as a risk factor in women is somewhat controversial. Few prospective studies have examined ... Thus, Lp(a) is a molecule with both lipoprotein and clotting potential. Lp(a) can be bound by LDL-C receptors and ...
The scope of subject matter covered in this work is extensive, ranging from assessment of the magnitude of the public health problem of cardiovascular disease and its risk factors among...
Other investigations have shown that primary prevention of cardiovascular disease is feasible using simple interventions. This book provides a comprehensive approach to cardiovascular wellness from a clinical perspective.
499 mg/dL] in adults aged 20 years and older is addressed by reducing atherogenic risk factors (eg, T2DM, ... level B).92 In other words, the 2018 AHA/ACC guidelines did not recommend additional pharmacologic therapy beyond statins in ...